RECRUITING

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators are evaluating the postoperative outcomes in patients undergoing total knee arthroplasty that receive either systemic lidocaine or ultrasound-guided adductor canal block as part of their anesthetic plan.

Official Title

The Efficacy of Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty: a Randomized, Double-blinded, Non-inferiority Study

Quick Facts

Study Start:2021-03-01
Study Completion:2024-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04828083

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ASA PS 1-3 patients undergoing primary, unilateral total knee arthroplasty
  1. * ASA PS classification of 4 or greater
  2. * Pre-existing neuropathy
  3. * Coagulopathy
  4. * Chronic opioid consumption (\>3 months)
  5. * Infection at the site
  6. * Known allergy to study medications (lidocaine)
  7. * High grade atrioventricular block (cardiac conduction system impairment)
  8. * A history of CVA/TIA
  9. * Currently using lidocaine patches
  10. * Known liver disease

Contacts and Locations

Study Contact

Vendhan Ramanujam, M.D.
CONTACT
401-444-5172
vramanujam@lifespan.org

Principal Investigator

Vendhan Ramanujam, M.D.
PRINCIPAL_INVESTIGATOR
Rhode Island Hospital, Brown University

Study Locations (Sites)

Rhode Island Hospital
Providence, Rhode Island, 02903
United States

Collaborators and Investigators

Sponsor: Rhode Island Hospital

  • Vendhan Ramanujam, M.D., PRINCIPAL_INVESTIGATOR, Rhode Island Hospital, Brown University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-03-01
Study Completion Date2024-11-30

Study Record Updates

Study Start Date2021-03-01
Study Completion Date2024-11-30

Terms related to this study

Additional Relevant MeSH Terms

  • Arthroplasty, Replacement, Knee
  • Total Knee Arthroplasty